Author/Authors :
Reimann، نويسنده , , Maurice and Lee، نويسنده , , Soyoung and Loddenkemper، نويسنده , , Christoph and Dِrr، نويسنده , , Jan R. and Tabor، نويسنده , , Vedrana and Aichele، نويسنده , , Peter and Stein، نويسنده , , Harald and Dِrken، نويسنده , , Bernd and Jenuwein، نويسنده , , Thomas and Schmitt، نويسنده , , Clemens A.، نويسنده ,
Abstract :
Summary
ted RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage response (DDR). In contrast, Myc activation—although producing a DDR as well—is known to primarily elicit an apoptotic countermeasure. Using the Eμ-myc transgenic mouse lymphoma model, we show here in vivo that apoptotic lymphoma cells activate macrophages to secrete transforming growth factor β (TGF-β) as a critical non-cell-autonomous inducer of cellular senescence. Accordingly, neutralization of TGF-β action, like genetic inactivation of the senescence-related histone methyltransferase Suv39h1, significantly accelerates Myc-driven tumor development via cancellation of cellular senescence. These findings, recapitulated in human aggressive B cell lymphomas, demonstrate that tumor-prompted stroma-derived signals may limit tumorigenesis by feedback senescence induction.